These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 34532390)
1. Tribbles pseudokinase 3 ( Wang RQ; He FZ; Meng Q; Lin WJ; Dong JM; Yang HK; Yang Y; Zhao M; Qiu WT; Xin YJ; Zhou ZL Ann Transl Med; 2021 Aug; 9(15):1253. PubMed ID: 34532390 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway. Wang S; Wang C; Li X; Hu Y; Gou R; Guo Q; Nie X; Liu J; Zhu L; Lin B Cancer Cell Int; 2020; 20():418. PubMed ID: 32874132 [TBL] [Abstract][Full Text] [Related]
3. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection. Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525 [TBL] [Abstract][Full Text] [Related]
4. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
5. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis. Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348 [TBL] [Abstract][Full Text] [Related]
6. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway. Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845 [TBL] [Abstract][Full Text] [Related]
7. Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression. Wang WL; Hong GC; Chien PJ; Huang YH; Lee HT; Wang PH; Lee YC; Chang WW Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33334065 [TBL] [Abstract][Full Text] [Related]
8. TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis. Chen QZ; Chen Y; Li X; Liu H; Sun XL Curr Med Sci; 2022 Oct; 42(5):932-940. PubMed ID: 36245025 [TBL] [Abstract][Full Text] [Related]
9. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520 [TBL] [Abstract][Full Text] [Related]
10. PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells. Guo J; Lan Z Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):37-45. PubMed ID: 31852247 [No Abstract] [Full Text] [Related]
11. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion. Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q Front Immunol; 2023; 14():1290839. PubMed ID: 38235126 [TBL] [Abstract][Full Text] [Related]
12. TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway. Shen P; Zhang TY; Wang SY Exp Ther Med; 2021 Apr; 21(4):313. PubMed ID: 33717256 [TBL] [Abstract][Full Text] [Related]
13. TRIB3 Promotes the Malignant Progression of Bladder Cancer: An Integrated Analysis of Bioinformatics and Yang J; Lin J; An J; Zhao Y; Jing S; Yu M; Zhu Y; Yao Y Front Genet; 2021; 12():649208. PubMed ID: 33841505 [TBL] [Abstract][Full Text] [Related]
14. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway. Bao XY; Sun M; Peng TT; Han DM Cancer Biomark; 2021; 31(4):307-315. PubMed ID: 33896816 [TBL] [Abstract][Full Text] [Related]
15. KITENIN is associated with activation of AP-1 target genes via MAPK cascades signaling in human hepatocellular carcinoma progression. Cho SB; Park YL; Park SJ; Park SY; Lee WS; Park CH; Choi SK; Heo YH; Koh YS; Cho CK; Chung IJ; Kim KK; Kim S; Joo YE Oncol Res; 2011; 19(3-4):115-23. PubMed ID: 21473287 [TBL] [Abstract][Full Text] [Related]
16. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma. Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956 [TBL] [Abstract][Full Text] [Related]
17. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway. Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887 [TBL] [Abstract][Full Text] [Related]
18. TRIB3 inhibits proliferation and promotes osteogenesis in hBMSCs by regulating the ERK1/2 signaling pathway. Zhang C; Hong FF; Wang CC; Li L; Chen JL; Liu F; Quan RF; Wang JF Sci Rep; 2017 Sep; 7(1):10342. PubMed ID: 28871113 [TBL] [Abstract][Full Text] [Related]
19. TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient deficiency survival factor. Örd T; Örd D; Adler P; Vilo J; Örd T Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2492-505. PubMed ID: 26094770 [TBL] [Abstract][Full Text] [Related]
20. [Tribbles pseudokinase 3 inhibits the adipogenic differentiation of human adipose-derived mesenchymal stem cells]. Bai XS; Lv LW; Zhou YS Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Feb; 52(1):1-9. PubMed ID: 32071456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]